Latest News

Schwab offers broader diversification with 121 holdings and lower costs, while State Street diversifies away from REITs and delivers higher income at 3.2%.

The innovator's dilemma is hitting hard in the remittance space.

Nebius Group's Q2 revenue surged 454% year-over-year to over $582 million, driven by faster capacity ramps, with analysts bullish but price targets suggesting shares are fairly valued near $230.

Record sensor orders driven by AI and aerospace demand offset ERP delays.

ORLADEYO revenue hit $158.2M with 10% growth as pediatric launch exceeded expectations.

Portfolio hits $13B as legacy credit assets resolve and origination surges.

You can teach an old dog some new tech tricks.

Business is going great at Astronics right now -- but what about the stock price?

This important characteristic is often overlooked, but it's essential.

What Happened? Shares of materials and photonics company Coherent (NYSE:COHR) jumped 8.8% in the afternoon session after a strong earnings report and positiv...

What Happened? Shares of mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) jumped 12.8% in the afternoon session after the company reported second-...

Embraer posted a Q2 earnings beat, raised full-year EBIT margin and free cash flow guidance, and grew its backlog to $34.5 billion, gaining ground on Boeing and Airbus.

The insider's equity holdings declined 28% through open-market transactions, leaving him with 51,514 shares valued at approximately $10 million.

Occupancy rebounds for first time since IPO as management pursues strategic divestitures.

Enrollment completed six months early; $1.5B cash runway into 2029.

Occupancy surged to 99.1% as acquisition volume jumped to $291 million in the quarter.

Revenue surged 24% as system-wide sales topped $1 billion for the first time.

Three divisions posted double-digit growth as leverage hit a four-year low.

Cloud revenue surged 12.6% as AI adoption accelerated across enterprise customers.

Micron investors are feeling bullish thanks to new demand indicators and other factors.

VanEck targets established pharma giants with lower costs and volatility, while Invesco pursues high-growth biotech companies. One delivered stronger returns; the other weathered downturns better.

Should stock investors start selling now? History offers some lessons.

Borr Drilling (NYSE:BORR) reported lower second-quarter adjusted EBITDA and a wider net loss as rig transitions, startup costs for the Odin rig, higher fuel and insurance expenses, and a credit-loss provision weighed on results. Management said it expects a significant sequential improvement in the

Candel Therapeutics (NASDAQ:CADL) is advancing two off-the-shelf viral immunotherapy candidates designed for local administration intended to generate systemic immune responses against tumors, Chief Scientific Officer Francesca Barone said at the Canaccord Genuity Growth Conference in Boston. The c

American Integrity Insurance Group (NYSE:AII) reported record second-quarter earnings and voluntary new-business production, as the Florida-focused property insurer expanded in key in-state markets and continued building its presence across the Southeast. The company generated net income of $34.1 m